NEOCHEMICAL - Trademark Details
Status: 404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Image for trademark with serial number 79016306
Serial Number
79016306
Registration Number
3187604
Word Mark
NEOCHEMICAL
Status
404 - U.S. registration cancelled because International Registration cancelled in whole or in part
Status Date
2015-07-20
Filing Date
2005-07-19
Registration Number
3187604
Registration Date
2006-12-19
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260105, 270301 - Circles made of broken or dotted lines. Geometric figures forming letters or numerals, including punctuation.
Published for Opposition Date
2006-10-03
Attorney Name
Law Office Assigned Location Code
L60
Employee Name
NELSON, EDWARD H
Statements
Indication of Colors claimed
The color(s) blue is/are claimed as a feature of the mark.
Desription of the Colors Claimed
The color blue appears in all the letters and the geometric shape forming in the letter "O".
Goods and Services
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of gastrointestinal /diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of stroke; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, cognitive disorders, schizophrenia, depression; pharmaceutical preparations for the treatment of substance abuse disorders, namely alcoholism and drug addiction; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of yeast infections; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for the treatment of pulmonary disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of gynecological disorders, namely premenstrual syndrome, endometreosis, yeast infections, menstrual irregularities; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; pharmaceutical preparations for use in smoking cessation preparations; pharmaceutical preparations for use in tissue and skin repair preparations; pharmaceutical preparations for use in acne medication; pharmaceutical preparations for use in allergy medication; pharmaceutical preparations for use in antacids; pharmaceutical preparations for use in anthelmintics; pharmaceutical preparations for use in antiarrhythmics; pharmaceutical preparations for use in antibiotics; pharmaceutical preparations for use in anticoagulants; pharmaceutical preparations for use in anticonvulsants; pharmaceutical preparations for use in antidepressants; pharmaceutical preparations for use in antiemetics; pharmaceutical preparations for use in antiflatulants; pharmaceutical preparations for use in antihistamines; pharmaceutical preparations for use in antihypertensives; pharmaceutical preparations for use in anti-infectives; pharmaceutical preparations for use in anti-inflammatories; pharmaceutical preparations for use in antiparasitics; pharmaceutical preparations for use in antibacterials; pharmaceutical preparations for use in antifungals; pharmaceutical preparations for use in antivirals; pharmaceutical preparations for use in burn relief medication; pharmaceutical preparations for use in calcium channel blockers; pharmaceutical preparations for use in central nervous system depressants; pharmaceutical preparations for use in central nervous system stimulants; pharmaceutical preparations for use in cough treatment medication; pharmaceutical preparations for use in diarrhea medication; pharmaceutical preparations for use in gastrointestinal medication; pharmaceutical preparations for use in glaucoma agents; pharmaceutical preparations for use in hydrocortisone; pharmaceutical preparations for use in hypnotic agents; pharmaceutical preparations for use in sedatives; pharmaceutical preparations for use in ophthalmic preparations; veterinary preparations, namely, antibiotics, antiparasitics, antiseptics, antimycotics, antihistamines, anti-inflammatories, local anaesthetics, biomaterials, veins therapeutics, antidiabetics, antirheumatics, moisturizers, analgesics, cortico steroids, vitamins, anti-asthmatics, cytostatics, vaccines, veterinary preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, Bluecomb, pneumonia; veterinary preparations for animals and poultry to give newborn animals and birds a healthy start; veterinary preparations for the treatment of vitamin deficiencies; veterinary preparations for the treatment of nutritional muscular dystrophy; veterinary preparations for the treatment of arthritis, muscle soreness and sprains; veterinary preparations for udder care; veterinary preparations for the treatment of parasites; veterinary pharmaceuticals for parturition induction in swine; veterinary preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; veterinary preparations for the treatment of swine bacterial infectious diseases; veterinary preparations for the treatment of infectious diseases in poultry; veterinary preparations for respiratory and reproductive diseases in cattle; veterinary preparations for periodontal diseases; veterinary preparations for the treatment of bacterial infections in dogs; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters, bandages for dressings; material for stopping teeth, dental wax; all purpose disinfectants; preparations for destroying vermin; fungicides, herbicides for agricultural use; sanitary sterilizing compositions; antiseptic preparations; disinfectant compositions for hygienic purposes
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2013-09-27
Primary Code
005
Correspondences
Name
Jan Tamulewicz
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
0864777
International Registration Date
2005-07-19
International Publication Date
2005-11-24
International Renewal Date
2015-07-19
Auto Protection Date
2007-05-03
International Status
102 - Death of IR (Dead as a Result of Non-Renewal, Renunciation or Cancellation by Holder of International Registration)
International Status Date
2015-07-20
Priority Claimed In
True
Priority Claimed Date
2005-03-09
First Refusal In
True
Trademark Events
Event DateEvent Description
2005-11-03SN ASSIGNED FOR SECT 66A APPL FROM IB
2005-11-10NEW APPLICATION ENTERED IN TRAM
2006-02-07ASSIGNED TO EXAMINER
2006-02-08NON-FINAL ACTION WRITTEN
2006-02-09NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2006-02-10REFUSAL PROCESSED BY MPU
2006-02-13NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2006-03-03REFUSAL PROCESSED BY IB
2006-05-16TEAS REVOKE/APPOINT ATTORNEY RECEIVED
2006-05-16ATTORNEY REVOKED AND/OR APPOINTED
2006-05-26TEAS RESPONSE TO OFFICE ACTION RECEIVED
2006-05-26CORRESPONDENCE RECEIVED IN LAW OFFICE
2006-06-24TEAS/EMAIL CORRESPONDENCE ENTERED
2006-07-18APPROVED FOR PUB - PRINCIPAL REGISTER
2006-08-04ASSIGNED TO LIE
2006-08-05LAW OFFICE PUBLICATION REVIEW COMPLETED
2006-09-13NOTICE OF PUBLICATION
2006-10-03PUBLISHED FOR OPPOSITION
2006-12-19REGISTERED-PRINCIPAL REGISTER
2007-07-24FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2007-07-25FINAL DISPOSITION PROCESSED
2007-07-25FINAL DISPOSITION NOTICE SENT TO IB
2008-03-28FINAL DECISION TRANSACTION PROCESSED BY IB
2012-12-21NEW REPRESENTATIVE AT IB RECEIVED
2013-09-27CANCELLED SECTION 71
2014-05-27TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
2014-11-03GENERIC MADRID TRANSACTION CREATED
2014-11-03GENERIC MADRID TRANSACTION SENT TO IB
2015-01-08NEW REPRESENTATIVE AT IB RECEIVED
2015-06-05TOTAL INVALIDATION PROCESSED BY THE IB
2016-02-05DEATH OF INTERNATIONAL REGISTRATION
2016-02-05NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED